Colpaert; Francis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Colpaert; Francis.The latest application filed is for "novel derivatives of aryl--methanone, their method of preparation and their use as medicinal products".

Company Profile

0.12.8

Colpaert; Francis - Puylaurens N/A FR
Colpaert; Francis - Le Vesinet FR
Colpaert; Francis - Vesinet FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products Grant 8,669,250 - Vacher , et al. March 11, 2	2014-03-11
Use of pyridin-2-yl-methylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin Grant 8,609,694 - Colpaert , et al. December 17, 2	2013-12-17
Novel Derivatives Of Aryl--methanone, Their Method Of Preparation And Their Use As Medicinal Products App 20120115860 - Vacher; Bernard ; et al.	2012-05-10
Pyridin-2-YL Methylamine Derivatives for Treating Opiate Dependence App 20120088792 - Colpaert; Francis ; et al.	2012-04-12
Pyridin-2-yl-methylamine derivatives for treating opiate dependence Grant 8,106,074 - Colpaert , et al. January 31, 2	2012-01-31
Pyridin-2-yl-methylamine Derivatives For Treating Opiate Dependence App 20100099709 - COLPAERT; Francis ; et al.	2010-04-22
Aryl-[4-halo-4(heteroarylmethylamino)-methyl]-piperidin-1-1yl]-methanone derivatives, methods for production and use thereof as medicaments Grant 7,547,700 - Vacher , et al. June 16, 2	2009-06-16
3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia Grant 7,235,568 - Vacher , et al. June 26, 2	2007-06-26
3-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia Grant 7,163,957 - Vacher , et al. January 16, 2	2007-01-16
3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derviatives and use thereof as medicines for treating schizophrenia App 20060264471 - Vacher; Bernard ; et al.	2006-11-23
Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin App 20060241141 - Colpaert; Francis ; et al.	2006-10-26
Novel aryl-[4-halo-4(heteroarylmethylamino)-methyl]-piperidin-1-1yl]-metha- none derivatives, methods for production and use thereof as medicaments App 20060100244 - Vacher; Bernard ; et al.	2006-05-11
3-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia App 20060014827 - Vacher; Bernard ; et al.	2006-01-19
Pyridin-2-yl-methylamine derivatives for treating opioid dependence App 20050065348 - Colpaert, Francis ; et al.	2005-03-24
Aminopiperidine 4-oxo-4H-chromen-2-yl compounds Grant 5,214,055 - Peglion , et al. May 25, 1	1993-05-25
New aminomethylpiperidine compounds Grant 5,192,775 - Malen , et al. March 9, 1	1993-03-09
Aminopiperidine indanyl and benzocyclobutene compounds Grant 5,189,045 - Peglion , et al. February 23, 1	1993-02-23
4-fluorobenzoic compounds with 5-HT.sub.2 - and .alpha..sub.1 -antagonistic activities Grant 5,077,288 - Lavielle , et al. December 31, 1	1991-12-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.